Hunan Er-Kang Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
193,693.30
287,411.60
598,985.40
781,651.60
514,799.10
210,670.90
Depreciation, Depletion & Amortization
39,641.60
73,918.50
95,211.60
115,719.60
128,597.50
128,928.90
Other Funds
-
10,500.00
1,985,571.40
12,550.80
6,679.40
65,676.10
Funds from Operations
238,765.70
358,308.90
691,501.70
953,090.40
773,951.00
412,813.60
Changes in Working Capital
64,544.50
188,499.10
196,599.50
450,915.50
73,094.50
272,832.30
Net Operating Cash Flow
174,221.20
169,809.70
494,902.20
502,174.90
700,856.50
139,981.30
Capital Expenditures
203,976.20
527,423.60
570,534.80
1,145,740.70
258,915.00
Sale of Fixed Assets & Businesses
-
213.20
-
1,446.20
998.80
Purchase/Sale of Investments
-
800.00
100,700.00
140,000.00
89,894.60
Net Investing Cash Flow
230,839.10
611,375.50
650,721.30
1,303,248.90
173,023.30
Cash Dividends Paid - Total
23,979.80
23,920.00
45,448.00
102,836.10
41,252.10
Issuance/Reduction of Debt, Net
-
303,612.00
164,804.00
153,315.90
-
Net Financing Cash Flow
23,979.80
290,192.00
1,775,319.40
243,601.20
34,572.70
Net Change in Cash
80,597.80
151,373.80
1,629,401.30
1,018,049.90
461,533.60
Free Cash Flow
29,755.00
357,613.80
75,632.60
643,565.80
441,941.40
Deferred Taxes & Investment Tax Credit
334.20
9,016.60
141.70
3,241.40
9,863.80
7,537.70
Net Assets from Acquisitions
9,991.40
85,875.10
-
39,513.90
6,901.60
Other Sources
3,126.40
2,510.00
20,513.50
20,559.60
1,900.00
Exchange Rate Effect
-
-
9,901.00
26,625.20
31,726.80
Other Uses
19,998.00
-
-
-
-
About Hunan Er-Kang Pharmaceutical Co.
View Profile
